View in EDS PDF Full Text

Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group.

Saved in:
Bibliographic Details
Title: Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group.
Authors: Lübbert, Michael1 michael.luebbert@uniklinik-freiburg.de, Suciu, Stefan2, Hagemeijer, Anne3, Rüter, Björn1, Platzbecker, Uwe4, Giagounidis, Aristoteles5, Selleslag, Dominik6, Labar, Boris7, Germing, Ulrich8, Salih, Helmut9, Muus, Petra10, Pflüger, Karl-Heinz11, Schaefer, Hans-Eckart12, Bogatyreva, Lioudmila, Aul, Carlo13, Witte, Theo14, Ganser, Arnold15, Becker, Heiko1, Huls, Gerwin, Helm, Lieke16
Source: Annals of Hematology. Jan2016, Vol. 95 Issue 2, p191-199. 9p.
Database: Academic Search Ultimate
Description
ISSN:09395555
DOI:10.1007/s00277-015-2547-0